The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways
Currently, the treatment of hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) [HBV-HCC] relies on blunt tools that are unable to offer effective therapy for later stage pathogenesis. The potential of miRNA to treat HBV-HCC offer a more targeted approach to managing this lethal carcin...
Main Authors: | Kurt Sartorius, Leo Swadling, Ping An, Julia Makarova, Cheryl Winkler, Anil Chuturgoon, Anna Kramvis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/7/746 |
Similar Items
-
The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation
by: Kurt Sartorius, et al.
Published: (2021-04-01) -
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus
by: Yaojia Ma, et al.
Published: (2022-10-01) -
Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis
by: Anja Schollmeier, et al.
Published: (2023-03-01) -
Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis
by: Fei Wang, et al.
Published: (2023-12-01) -
Hepatitis B Virus HBx Protein Interactions with the Ubiquitin Proteasome System
by: Marissa M. Minor, et al.
Published: (2014-11-01)